Pharma Export Boom: Sun Pharma, Dr Reddy’s, Cipla — Which Stock Will Capture US Market Growth Post-Trade Deal? by NDTV Profits | February 9, 2026 7:13 am | Latest Posts, Market, Trending News For investors seeking maximum leverage from the trade deal, Dr. Reddy’s offers the most compelling risk-reward profile.
